689 ATRC-101 Drives Potent Single-Agent Activity in Mouse Syngeneic Tumor Models via a Novel Cellular Mechanism of Action
Main Authors: | Felix Chu, Michael Harbell, Amy Manning-Bog, Alexander Scholz, Ngan Nguyen, Norman Greenberg, William Robinson, Daniel Emerling, Tito Serafini, Wei Cao, Yvonne Leung, Nikhil Vad, Anne Ye, Daniel Santos, Cathrin Czupalla, John Vivian, Carlene Williams, Judevin Sapugay, Shaun Lippow, Chantia Carroll, Lance Kates, Benjamin Haugen, Gary Bolton, Mark Armanini, Iraz Aydin, Mark Whidden, Mauricio Velasco-Delgado, Erin Wechsler |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
P689: Withdrawn
Published: (2023-01-01) -
A methodology for uncertainty quantification and sensitivity analysis for responses subject to Monte Carlo uncertainty with application to fuel plate characteristics in the ATRC
by: Dean Price, et al.
Published: (2022-03-01) -
Câncer de Mama em Mulheres Jovens: Análise de 12.689 Casos
by: Aline Barros Pinheiro, et al.
Published: (2013-09-01) -
Thioflavin T Monitoring of Guanine Quadruplex Formation in the rs689-Dependent INS Intron 1
by: Ana Lages, et al.
Published: (2019-06-01) -
689 Pharmacodynamic results with talquetamab and daratumumab in patients with relapsed/refractory multiple myeloma in TRIMM-2
by: Lien Vandenberk, et al.
Published: (2023-11-01)